Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases

Details for Australian Patent Application No. 2006302435 (hide)

Owner Schering Corporation

Inventors Parry, David A.; Dwyer, Michael P.; Guzi, Timothy J.; Paruch, Kamil

Agent Griffith Hack

Pub. Number AU-A-2006302435

PCT Pub. Number WO2007/044441

Priority 60/724,158 06.10.05 US

Filing date 4 October 2006

Wipo publication date 19 April 2007

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/044441 Priority application(s): WO2007/044441

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006302443-Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

2006302429-Treatment of peripheral arterial occlusive disease